HÖHilal Öztürk

Hilal Öztürk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hilal Öztürk has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Investigation of the Effects of Two Major Green Tea Ingredients on Seizure-Associated High-Frequency Oscillations In Vitro

    by Hilal Öztürk

    Background: This study aimed to investigate the effects of epigallocatechin gallate (EGCG) and L-theanine, two important ingredients of green tea with rich polyphenol content and neurobiological effects, o n c ortical h igh-frequency oscillations (HFOs), which are considered seizure markers in epilepsy. Materials and Methods: Epilepsy-like discharges were induced in fresh mouse brain slices by applying 4-aminopyridine (4-AP, 100 μM). HFOs were identified t hrough electrophysiological recordings, and power analyses were performed for the 0-40 Hz frequency band. HFOs were examined in two sub-bands: ripple (80-200 Hz) and fast ripple (250-500 Hz). Subsequently, changes in power were evaluated after the application of EGCG (50 μM, n=10) and L-theanine (50 μM, n=10).Results: EGCG administration significantly r educed p ower in the 0-40 Hz frequency band, which is associated with seizure activity, while significantly increasing the power in the ripple and fast ripple bands. L-theanine administration, on the other hand, significantly reduced the power in the 0-40 Hz and ripple bands, while increasing the power in the fast ripple band. Conclusions: HFOs are critical biomarkers in epilepsy for identifying seizure foci and understanding the mechanisms of epileptogenesis. The differing m odulatory e ffects of gr een tea ingredients EGCG and L-theanine on these frequency bands suggest that different mechanisms may be involved at the cellular level. This study is the first to identify the effects of these ingredients on HFOs. These results may contribute to the identification of dietary or pharmacological modulators of abnormal neuronal synchronization.

  • Topical but Not Systemic Epigallocatechin Gallate Reduces the Power of Cortical Oscillations: Evidence for Limited Blood-Brain Barrier Penetration

    by Hilal Öztürk, Esra Kabak, Selcen Abidin, İsMail Abidin

    Objective: Epigallocatechin-gallate (EGCG), a tea active ingredient widely consumed worldwide, is offered as a nutritional supplement, considered as a complementary therapeutic agent in the management of various diseases. While commercialized with an emphasis on its beneficial effects on the central nervous system, there are conflicting findings regarding EGCG's blood-brain barrier (BBB) penetration. Methods: This study investigated the functional effect of EGCG intake on brain oscillations via different routes of administration. Furthermore, the pharmacokinetic properties of EGCG are presented using SwissADME. For this purpose, two different experimental groups were formed, and EGCG was administered to each experimental group using a different method: intraperitoneally (n=6), topically (n=6). Results: In the experimental group that received intraperitoneal EGCG, no change was observed in the power spectrum and band-specific analyses in the electrocorticography recordings taken from the cortex. However, EGCG applied topically to the cerebral cortex caused a significant decrease in basal oscillations. In addition, a significant decrease was observed in delta (0.5-4 Hz), theta (4-8 Hz), and alpha (8-13 Hz) oscillations. It had a reducing effect on beta (13-30 Hz) and gamma (30-50 Hz) oscillations, but these results were not statistically significant. ADME results also supported the inability of EGCG to pass through the BBB based on properties such as molecular size and polarity. Conclusion: In conclusion, EGCG has a significant functional effect on brain oscillations when administered directly to the cerebral cortex, while intraperitoneal injection failed to show any similar effect. These comparative findings clearly show the critical role of the route of administration in achieving therapeutic efficacy. We suggest that nanoencapsulation or combination therapies with other therapeutic agents would be beneficial to allow sufficient EGCG to cross the BBB.

  • Chronic p75 neurotrophin receptor modulation with LM11A-31 attenuates seizure progression and network hyperexcitability in pentylenetetrazol kindling

    by Esra Kabak, Selcen Aydin-Abidin, Ayşe Yeşim Göçmen, Hilal Öztürk, Dilanur Köse, Harun Başoğlu, İsMail Abidin

  • Corrigendum to “Effect of L-theanine on the hippocampus, cerebral cortex and cerebellum of doxorubicin-treated rats” [Biochem. Biophys. Res. Commun.797 (2026) 153216]

    by Birgül Kural, Sevil Kör, Meltem Arıkan Malkoç, Hilal Öztürk, Tenzile Beyza Durmuş, Esin Yuluğ, Selcen Aydın-Abidin, İsMail Abidin, Asım Örem

  • Evaluation of Electrode Impedance, Sensing, and Pacing Threshold Changes at 12 Hours After Pacemaker Implantation

    by Serdar Karalük, Hilal Öztürk, Mustafa Balkaya, Kıvanç Yalın, Devrim Saribal

    Objective: The aim of this study was to evaluate the early changes in electrode impedance, sensing, and pacing threshold values within the first 12 hours after pacemaker implantation. Methods: A total of 50 patients who underwent device implantation between January and December 2024 were included in this prospective study. Lead impedance, sensing amplitude, and pacing threshold were measured immediately after implantation and reassessed at 12 hours post-implantation. Changes between the two time points were statistically analyzed. Results: Lead impedance values significantly decreased within the first 12 hours following implantation (p0.05). Both atrial and ventricular leads demonstrated similar patterns in impedance reduction without compromising sensing or pacing efficacy. Conclusion: This study demonstrates that a significant early decrease in lead impedance occurs within the first 12 hours after pacemaker implantation, while sensing and pacing thresholds remain stable. These findings confirm the short-term reliability of modern pacing and defibrillation leads and highlight the importance of early monitoring of lead parameters following device implantation.

  • Effect of L-theanine on the hippocampus, cerebral cortex and cerebellum of doxorubicin-treated rats

    by Birgül Kural, Sevil Kör, Meltem Arıkan Malkoç, Hilal Öztürk, Tenzile Beyza Durmuş, Esin Yuluğ, Selcen Aydin-Abi̇dİn, İsMail Abidin, Asım Örem


  • 3-Carene Modulates Baseline Brain Electrical Activity Without Suppressing 4-Aminopyridine-Induced Seizure Events: An In Vivo and In Vitro Electrophysiological Study

    by Ömer Faruk Kalkan, Hilal Öztürk, Osman Aktaş, Abdulhamit Yıldırım, Ali Yavuz Uzun, Zafer Şahin, Selcen Aydın Abidin, Dilanur Köse, Cansu Yılmaz, İsMail Abidin

    In the current study, we investigated the effects of 3-carene administration on basal brain activity and 4-aminopyridine (4-AP) induced epileptiform activity. Additionally, we examined the effects of asprosin on ECoG band powers. Thirty-five male Wistar rats were divided into five groups as follows: control (DMSO), 4-AP (2.5 mg/kg i.p.), 3-carene 10 mg/kg (i.p), 3-carene 50 mg/kg (i.p), 3-carene 50 mg/kg (i.p) post-treatment. Recordings lasting 60–70 min were conducted for all groups under ketamine/xylazine (90/10 mg/kg) anesthesia. Furthermore, we used thick acute horizontal hippocampal slices obtained from 30‑ to 35‑day‑old rats for in vitro experiments. Extracellular field potential recordings were evaluated in the CA1 region of the hippocampus. In vivo recordings revealed that intraperitoneal administration of 3-carene (10 mg/kg and 50 mg/kg) significantly suppressed basal brain activity across delta, theta, alpha, and beta bands. However, 3-carene failed to reduce epileptiform discharges induced by 4-AP. Complementary in vitro experiments using hippocampal and entorhinal cortex slices further confirmed the lack of anticonvulsant effect, as 3-carene did not alter the frequency or duration of 4-AP-induced ictal or interictal events. These findings suggest that while 3-carene modulates resting-state cortical oscillations, it lacks efficacy in suppressing seizure-like activity. The results highlight its potential as a neuromodulatory agent rather than a standalone anticonvulsant.


  • Effect of Gap-Junctıon Inhıbıtıon on High-Frequency Oscillations Under Hyperexcitability: An In Vitro Electrophysiological Study

    by Hilal Öztürk

    Objective: High Frequency Oscillations (HFO), covers the frequency band between 80-500 Hz component of the electrical activity of brain, is considered a marker for epileptic seizures. We investigated the contribution of gap-junction to HFOs in cortex. Methods: HFOs were investigated in two different frequency bands: 80-200 Hz accepted as ripple and 250-500 HZ as fast ripples. HFO’s detected from electrophysiological recordings of 4AP-induced seizures in fresh brain slices. Then, gap-junction blockers were applied and their effects on power of HFOs were followed. Effects of Flufanemic acid (100 μM, n=10), a connexin blocker, Probenecid (200 μM, n=8), a pannexin-1 blocker, were analyzed. Power spectrum analyses of the relevant frequency ranges were performed. The effects of the blockers on 0-40 Hz frequency also analyzed. Results: Flufenamic acid significantly reduced 0-40 Hz frequency band and ripple discharges, and had no effect on fast ripples. Probenecid application reduced the 0-40 Hz, ripple and fast ripple frequency range, but did not change significantly. Conclusion: This is the first study in which two gap junction blockers, flufenamic acid and probenecid, were applied under the same experimental conditions and their effectiveness was compared with each other. HFO has been the subject of many studies in recent years. The detection of these oscillations and their onset regions provide deep information about the seizure that will develop. Future studies will shed light on unanswered questions in epilepsy disease and contribute to the development of seizure pathogenesis and new treatment methods.

  • Sleep Deprivation Alters T Cell Dynamics: Melatonin as a Restorative Agent

    by Hilal Öztürk, Hakan Çalış, Yusuf Metin Gelmez, Günnur Deniz, Abdullah Yılmaz, Mahmut Alp Kılıç, Nermin Yelmen, Zozan Güleken, Devrim Saribal

    Sleep is an essential physiological function regulated by circadian rhythm and homeostatic regulation for emotional and physical health. Conversely, sleep deprivation (SD) is associated with weakened immune system function and overall health, which potentially leads to chronic diseases such as heart disease and diabetes. In this study, we aimed to investigate the role of regulatory T cells (Tregs) in the immune response to SD and the potential therapeutic effect of melatonin in modulating this response. For this purpose, 24 8‐week‐old male C57BL/6J mice were distributed into 4 groups: control, control with melatonin, SD, and SD with melatonin. Treg levels were assessed in peripheral blood and spleen samples with flow cytometry. According to the data, SD decreases the CD3 + T cells in blood but not in spleen samples. Moreover, Helios transcription factor expressing Treg cell levels are increased in both blood and spleen in the SD group, which indicates a possible immunosuppressive occurrence. Melatonin administration affected the numbers of total Tregs and particularly the numbers of Helios + Tregs and restored the T cell population similar to the normal levels. Our results suggest melatonin as a key regulatory component for SD‐induced immunological imbalance as well as reduced memory and effector Tregs and increased naïve Tregs. According to these findings, they highlight the immunological consequences of SD and the therapeutic promise of melatonin in restoring immune function.


  • Open Access

    Investigation of structural suitability of agmatine with glutamatergic ion channels: Molecular docking study

    by Hilal Öztürk, Nuri Yorulmaz

    Aim: Agmatine is considered a neurotransmitter that is expressed almost everywhere in the brain and is thought to act as a neuromodulator. There is evidence that it interacts with glutamatergic ion channels associated with physiological and pathological states such as excitability and hyperexcitability. In this study, possible relationships of seizure-related ion channels (KARs, AMPARs and NMDARs) with agmatine are discussed using molecular docking method. Material and Method: Information on glutamatergic ion channels was obtained from the Protein Data Bank. The 2D structure of agmatine and inhibitors of receptors were retrieved from NCBI PubChem in .sdf format. Simulation studies were carried out using the Auto Dock 4.2.6 software program. Results: Binding sites were determined. The binding energy of agmatine to these receptors was compared with reference molecules. In this case, the binding energy of agmatine to KAR, AMPAR and NMDARs is -5.73 kcal/mol, -5.41 kcal/mol and -4.01 kcal/mol, respectively. In addition, when compared with the binding energies of the glutamate molecule, approximate energy values were obtained. Conclusion: In conclusion, it can be said that Agmatine does not have the ability to structurally block the ionotrophic glutamate receptors AMPAR, KAR and NMDAR as a result of its weak bonds. However, it seems to have the ability to bond to the channel with binding energies close to glutamate binding. We think that agmatine binds to the receptor at the glutamate binding site, but instead of activating the receptor, it may have prevented the receptor from being activated by blocking the binding of glutamate.